Blankenship, K. M., Friedman, S. R., Dworkin, S., & Mantell, J. E. (2006). Structural interventions: Concepts, challenges and opportunities for research. Journal of Urban Health, 83 (1), 59-72.

Choopanya, K., Des Jarlais, D. C., Vanichseni, S., Kitayaporn, D., Mock, P. A., Raktham, S., Hireanras, K., Heyward, W. L., Sujarita, S., & Mastro, T. D. (2002). Incarceration and risk for HIV infection among injection drug users in Bangkok. Journal of Acquired Immune Deficiency Syndromes, 29 (1), 86-94.

Cleland, C. M., Deren, S., Fuller, C. M., Blaney, S., McMahon, J. M., Tortu, S., Des Jarlais, D. C., & Vlahov, D. (2007). Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Education and Behavior, 34 (2), 390-403.

Cleland, C. M., Des Jarlais, D. C., Perlis, T. E., Stimson, G., & Poznyak, V. (2007). HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health, 7, 271.

Deren, S., Fuller, C., Pouget, E. R., Blaney, S., Tortu, S., Kang, S. Y., McMahon, J. M., Andia, J. F., Des Jarlais, D. C., Johnson, B., Rosenblum, A., & Vlahov, D. (2003). Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. International Journal of Drug Policy, 14 (5), 373-379.

Deren, S., Robles, R., Andia, J., Colon, H. M., Kang, S. Y., & Perlis, T. (2001). Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999. Journal of Acquired Immune Deficiency Syndromes, 26 (2), 164-169.

Deren, S., Shedlin, M., Hamilton, T., & Hagan, H. (2002). Impact of the September 11th attacks in New York City on drug users: A preliminary assessment. Journal of Urban Health, 79 (3), 409-412.

Des Jarlais, D. C., & Semaan, S. (2005). Interventions to reduce the sexual risk behaviour of injecting drug users. International Journal of Drug Policy, 16 (Supplement 1), S58-S66.

Des Jarlais, D. C., & Semaan, S. (2008). HIV and other sexually transmitted infections in injection drug users and crack cocaine smokers. In K. K. Holmes, P. F. Sparling, W. E. Stamm, P. Piot, J. N. Wasserheit, L. Corey, L. Cohen &. D. H. Watts (Eds.), Sexually transmitted diseases (4th ed., 237-255). New York: Mc-Graw-Hill.

Des Jarlais, D. C., Friedmann, P., Grund, J-P., Milliken, J., Titus, S., Zadoretsky, C., Perlis, T., Bodrova, V., & Zemlianova, E. (2002). HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia. International Journal of Drug Policy, 13 (3), 165-170.

Des Jarlais, D. C., Hagan, H., Arasteh, K., McKnight, C., Perlman, D., & Friedman, S. R. (2007). Herpes simplex virus-2 and HIV among noninjecting drug users in New York City. Sexually Transmitted Diseases, 34 (11), 923-927.

Des Jarlais, D. C., Kling, R., Hammett, T. M., Ngu, D., Liu, W., Chen, Y., Binh, K. T., & Friedmann, P. (2007). Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project. AIDS, 21 (Supplement 8), S109-S114.

Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., Torian, L., Glebatis, D., Murrill, C., Monterroso, E., & Friedman, S. R. (2000). HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic. American Journal of Public Health, 90 (3), 352-359.

Des Jarlais, D. C., Perlis, T. E., Stimson, G. V., Poznyak, V., & WHO Phase II Drug Injection Collaborative Study Group (2006). Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO Drug Injection Study Phase II. BMC Public Health, 6:54.

Flom, P. L. (2005). A LATEX fledgling struggles to take flight. PracTEX Journal, 2.

Flom, P. L., & Strauss, S. M. (2003). Some graphical methods for interpreting interactions in logistic and OLS regression. Multiple Linear Regression Viewpoints, 29 (1), 1-7.

Flom, P. L., Friedman, S. R., Strauss, S. M., & Neaigus, A. (2004). A new measure of linkage between two sub-networks. Connections, 26 (1), 62-70.

Flom, P. L., Zenilman, J. M., Sandoval, M., Kottiri, B. J., & Friedman, S.R. (2005). Seroprevalence and correlates of Herpes Simplex Virus Type 2 infection among young adults in a low-income minority neighborhood. Journal of Infectious Diseases, 191 (5), 818-820.

Friedman, S. R. (2003). Thoughts on a theory of drug-use trends. Addiction Research and Theory, 11 (1), 43-45.

Friedman, S. R. (2000). What hath RAR wrought?. International Journal of Drug Policy, 11 (1), 37-39.

Friedman, S. R. (2002). Sociopharmacology of drug use: Initial thoughts. International Journal of Drug Policy, 13 (5), 341-347.

Friedman, S. R., & Knight, K. (2003). What is the role of structural interventions in HIV prevention?. University of California, San Francisco, Center for AIDS Prevention Studies Fact Sheet.

Friedman, S. R., & Reid, G. (2002). The need for dialectical models as shown in the response to the HIV/AIDS epidemic. International Journal of Sociology and Social Policy, 22, 177-200.

Friedman, S. R., & Touze, G. (2006). Policy bereft of research or theory: A failure of harm reduction science. International Journal of Drug Policy, 17 (2), 133-135.

Friedman, S. R., Bolyard, M., Maslow, C., Mateu-Gelabert, P., Sandoval, M., Ritvo, P., & Zenilman, J. (2007). Dificultades potenciales en la implementacion a nivel comunitario de la vacunacion contra el HIV: Lecciones de la vacunacion contra la hepatitis B. Actualizaciones En SIDA, 15 (58), 139-147.

Friedman, S. R., Bolyard, M., Mateu-Gelabert, P., Goltzman, P., Pawlowicz, M. P., Singh, D. Z., Touze, G., Rossi, D., Maslow, C., Sandoval, M., & Flom, P. L. (2007). Some data-driven reflections on priorities in AIDS network research. AIDS and Behavior, 11 (5), 641-651.

Friedman, S. R., Cavalieri, W., Crofts, N., Walsh, N., Madden, A., & Taylor, A. (2007). Hepatitis C prevention and care for injecting drug users. International Journal of Drug Policy, 18 (5), 333-334.

Friedman, S. R., de Jong, W., Rossi, D., Touze, G., Rockwell, R., Des Jarlais, D. C., & Elovich, R. (2007). Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy, 18 (2), 107-117.

Friedman, S. R., Kippax, S. C., Phaswana-Mafuya, N., Rossi, D., & Newman, C. E. (2006). Emerging future issues in HIV/AIDS social research. AIDS, 20 (7), 959-965.

Friedman, S. R., Lynch, J., Perlis, T., & Des Jarlais, D. C. (2000). Economic inequality, poverty, and laws against syringe access as predictors of metropolitan area rates of drug injection and HIV infection. In 2000 Global Research Network meeting on HIV prevention in drug-using populations: Third Annual Meeting Report (147-149). Rockville, MD: National Institute on Drug Abuse.

Friedman, S. R., Neaigus, A., Sandoval, M., Mateu-Gelabert, P., Flom, P. L., Kottiri, B. J., Fuld, J., Krauss, B., & Des Jarlais, D. C. (2002). What risk networks and social networks can contribute to understanding and preventing the spread of HIV. In 2001 Global Research Network meeting on HIV prevention in drug-using populations: Fourth Annual Meeting Report (19-25). Rockville, MD: National Institute on Drug Abuse.

Friedman, S. R., Perlis, T., & Des Jarlais, D. C. (2001). Laws prohibiting over-the-counter syringe sales to injection drug users: Relations to population density, HIV prevalence, and HIV incidence. American Journal of Public Health, 91 (5), 791-793.

Friedman, S., Rossi, D., & Flom, P. L. (2006). "Big events" and networks. Connections, 27 (1), 9-14.

Gwadz, M. V., Nish, D., Leonard, N. R., & Strauss, S. M. (2007). Gender differences in traumatic events and rates of post-traumatic stress disorder among homeless youth. Journal of Adolescence, 30 (1), 117-129.

Hagan, H. (2003). The relevance of attributable risk measures to HIV prevention planning. AIDS, 17 (6), 911-913.

Hagan, H., Des Jarlais, D. C., Stern, R., Lelutiu-Weinberger, C., Scheinmann, R., Strauss, S., & Flom, P. L. (2007). HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, 18 (5), 341-351.

Johnson, B. D., Golub, A., Deren, S., Des Jarlais, D. C., Fuller, C., & Vlahov, D. (2006). The nonimpact of the Expanded Syringe Access Program upon heroin use, injection behaviours, and crime indicators in New York City and State. Justice Research and Policy, 8 (1), 27-49.

Krahn, M. D., John-Baptiste, A., Yi, Q., Doria, A., Remis, R. S., Ritvo, P., & Friedman, S. (2005). Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada. Vaccine, 23 (13), 1549-1558.

Pouget, E. R., Deren, S., Fuller, C. M., Blaney, S., McMahon, J. M., Kang, S. Y., Tortu, S., Andia, J. F., Des Jarlais, D. C., & Vlahov, D. (2005). Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes, 39 (4), 471-477.

Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., & Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science and Medicine, 61 (5), 1026-1044.

Rindskopf, D. M., Strauss, S. M., Falkin, G. P., & Deren, S. (2003). Assessing the consequences of using self-report data to determine the correlates of HIV status: Conditional and marginal approaches. Multivariate Behavioral Research, 38 (3), 325-352.

Rockwell, R., Deren, S., Goldstein, M. F., Friedman, S. R., & Des Jarlais, D. C. (2002). Trends in the AIDS epidemic among New York City's injection drug users: Localized or citywide?. Journal of Urban Health, 79 (1), 136-146.

Rosenblum, A., Joseph, H., Fong, C., Kipnis, S., Cleland, C., & Portenoy, R. K. (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. Journal of the American Medical Association, 289 (18), 2370-2378.

Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des Jarlais, D. C., Flom, P. L., & Strauss, S. (2007). Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence, 89 (1), 1-12.

Stimson, G. V., Fitch, C., Des Jarlais, D., Poznyak, V., Perlis, T., Oppenheimer, E., & Rhodes, T. (2006). Rapid assessment and response studies of injection drug use: Knowledge gain, capacity building, and intervention development in a multisite study. American Journal of Public Health, 96 (2), 288-295.

Strauss, S. M., Rindskopf, D. M., Astone-Twerell, J. M., Des Jarlais, D. C., & Hagan, H. (2006). Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the US. Drug and Alcohol Dependence, 83 (1), 15-24.

Vassilev, Z. P., & Hagan, H. (2004). Highly active antiretroviral therapy for injection drug users: Physician-recommended strategies for enhanced adherence. Antiviral Therapy, 9 (3), 461.